The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Canadian profiling and targeted agent utilization trial (CAPTUR/PM.1): A phase II basket precision medicine trial.
 
Tanya Skamene
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; MorphoSys; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)
 
Daniel John Renouf
Honoraria - Celgene; Shire
Consulting or Advisory Role - Celgene; Shire
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Janessa J. Laskin
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche Canada
Research Funding - AstraZeneca (Inst); Roche Canada (Inst)
 
Philippe L. Bedard
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cascadian Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)
 
Steven J. M. Jones
No Relationships to Disclose
 
Cristiano Ferrario
Honoraria - Amgen; Astellas Oncology; Bayer Health; Pfizer
Consulting or Advisory Role - Janssen; Novartis; Roche
Research Funding - Abbvie (Inst); Alethia Biotherapeutics (Inst); Astellas Oncology (Inst); AstraZeneca (Inst); Cascadian Therapeutics (Inst); Celldex (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis
 
James Whitlock
Honoraria - Jazz Pharmaceuticals; Medical Learning Group
Consulting or Advisory Role - Amgen; Amgen; eviti; Gilead Sciences; Janssen-Ortho; Jazz Pharmaceuticals; Shire
Research Funding - GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
 
Joan Petrie
No Relationships to Disclose
 
Patrick Sullivan
Stock and Other Ownership Interests - Amgen; Novartis
Honoraria - Novartis; Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Dora Nomikos
No Relationships to Disclose
 
Bingshu E. Chen
No Relationships to Disclose
 
Janet Dancey
Leadership - 3Ci
Honoraria - 3Ci
Consulting or Advisory Role - Roche Canada
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)